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Case RepoRt 
A 44-year-old morbidly obese male with history of dyspnea on 
exertion of functional New York Heart Association (NYHA) functional 
Class II and foot oedema since three months presents to the 
emergency department with respiratory distress and hypoxia (an O2 
saturation of 80% at room air). 
On arrival he had a Blood Pressure (BP) of 140/85mmHg, Heart 
Rate (HR) of 98 beats per minute and a respiratory rate of 24 per 
minute. He had no fever. The O2 saturation increased to 92% 
after administeeing nasal oxygen and his respiratory distress was 
improved. He had un-remarkable findings in his heart and lung 
exam except for tachycardia and a grade of 2/6 systolic murmur 
at left sternal border. The patient was found to have a prominent 
abdomen with increased liver span and 3+ bilateral pitting oedema 
of lower extremities.
Transthoracic Echocardiography showed a preserved left ventricular 
function (left ventricular ejection fraction = 50%) with a severely 
enlarged RV with moderate systolic dysfunction. The tricuspid 
valve was severely regurgitant with a Tricuspid Regurgitant Gradient 
(TRG) of 70mmHg.
A semi-mobile large (3.6cm X 2.2cm) pedunculated mass in favour 
of thrombus was obvious in his RV cavity attached to the lateral 
papillary muscle adjacent to the tricuspid valve leaflet. The main 
pulmonary artery and its branches seemed dilated without any 
evidence of thrombus.
He was transferred to the Coronary Care Unit (CCU) with an 
impression of acute PTE  and intra venous heparin was started. 
Pulmonary CT angiography showed a sub-segmental PE in the 
left lung and RiHT and color doppler sonography of the lower limb 
veins was compatible with acute Deep Vein Thrombosis (DVT) of 
left popliteal veins [Table/Fig-1,2]. The laboratory tests in terms of 
complete blood count and renal function tests were within normal 
limits and the troponin was negative.
Considering stable vital sign and an estimation of intermediate-low 
risk for his acute PTE, he was candidate for anticoagulant therapy. 
His clinical course was uneventful and after 10 days of treatment with 
heparin and warfarin the RV size and function improved significantly, 
TRG reduced to 40 mmHg and  the RV thrombus was decreased 
in size (1cm X 2cm) and appeared immobile and fixed in the lateral 
papillary muscle. On follow-up after a month he was doing well.
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aBstRaCt
Right Heart Thrombus (RiHT) management is really controversial, and appropriate guidelines are not present for the management. In 
patients referring with RiHT and Pulmonary Embolism (PE), there are three ways of managing these patients. Out of the three, one is 
thrombectomy, which is with high risk taking in mind the comorbidities these patients have. The other is using thrombolytic which, in 
many cases is contraindicated or with high risk. The other less effective way is full anticoagulation. It is really controversial to choose 
between these ways of management and no clear approach is present. The case presented is a 44-year-old morbid obese male with 
history of dyspnea on exertion (functional Class II) and foot oedema or the last three months, who was transferred to the emergency 
department with respiratory distress and hypoxia. Echocardiography was done for the patient which showed moderate Right Ventricular 
(RV) dysfunction with severe RV enlargement and a severe Tricuspid Regurgitation (TR) with TR gradient of 70mmHg. He also had 
a semi-mobile large pedunculated mass in favour of a clot in his RV cavity. With the impression of PE heparin was administered 
to the patient and he was admitted in the coronary care unit. Pulmonary Computed Tomography (CT) angiography showed sub-
segmental Pulmonary Thromboendarterectomy (PTE) in the left lung. He had negative cardiac markers and stable vital signs and so full 
anticoagulation was chosen for his treatment. His clinical course was uneventful and after 10 days of treatment the RV size and function 
improved significantly. On follow-up after a month he was doing well. Although recent Guidelines of European Society of Cardiology in 
management of acute PE stated that RiHT, particularly mobile, are associated with a significantly increased early mortality risk in patients 
with acute PE. Immediate therapy is mandatory, but optimal treatment is controversial in the absence of controlled trials. Thrombolysis 
and embolectomy are probably both effective while anticoagulation alone seems to be less effective.     
[table/Fig-1]: Mediastinal view of the pulmonary CT angiography showing segmental 
PE in the left lung (a)
Mohammad Mostafa Ansari-Ramandi et al., Acute Right Sided Heart Failure with Right Heart Thrombus and Pulmonary Thromboembolism  www.jcdr.net
Journal of Clinical and Diagnostic Research. 2016 Sep, Vol-10(9): OD03-OD044
DisCussion
Right heart thrombus (RiHT) is present in 3%-4% of patients with 
PTE and its management is controversial and appropriate guidelines 
for the management of the same are lacking [1]. In patients with 
RiHT there is high incidence of PE [2-4].
Two types of RiHT have been defined. The type A thrombi have high 
mobility and are associated with DVT. Type B thrombi are small and 
immobile associated with right sided heart abnormalities. PE and 
mortality is more in type A thrombi as compared to type B thrombi 
[5].
Patients having PE with RiHT have shorter duration of symptoms, 
lower blood pressure, higher pulse rate, more frequency of 
congestive heart failure and right ventricular wall hypokinesia and 
poor prognosis [3].
Although, there are several different modalities for the treatment 
of RiHT which include anticoagulation with heparin, thrombolysis, 
catheter embolectomy, and surgical embolectomy, but there is no 
clear guideline for their use [6].  
Out of the four, one is surgical thrombectomy which accompanies 
significant risk, considering the comorbidities these patients 
may have. The other is using thrombolytic which in many cases 
may be contraindicated. The other less effective way is full dose 
anticoagulation therapy. It is really controversial to choose between 
these [7].  
Recent guidelines of European Society of Cardiology in management 
of acute PE stated that RiHT, particularly mobile, are associated with 
a significantly increased early mortality risk in patients with acute PTE 
but in our case the patient had good outcome by anticoagulation 
therapy. Immediate therapy is mandatory, but optimal treatment is 
controversial in the absence of controlled trials. Thrombolysis and 
embolectomy are probably both effective while anticoagulation 
alone seems to be less effective [1]. In our case taking in mind the 
low to intermediate risk profile of the patient, full anticoagulation was 
chosen for the patient and great response was seen.
ConClusion
According to the right heart thrombi European registry, 30 
days prognosis in patient with RiHT is predominantly related to 
hemodynamic consequences of PTE and not to the characteristics 
of RiHT. Therefore, recommended methods of prognostic PE 
stratification are applicable also to patients with RiHT. RiHT patients 
with low risk PE defined by simplified Pulmonary Embolism Severity 
Index (sPESI) 0 or by hemodynamic stability with preserved right 
ventricular function have good prognosis and anticoagulation seems 
to be sufficient.
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[table/Fig-2]: Mediastinal view of the pulmonary CT angiography showing (a), right 
heart thrombus and (b), pulmonary infarct
